Hannah Joseph Hospital reported a 55.1% increase in net profit to ₹1,118.12 lakh for the financial year ended March 31, 2026, compared to ₹720.99 lakh in the previous year. Revenue from operations rose 18.7% to ₹9,205.17 lakh for FY26, up from ₹7,753.13 lakh in FY25. The Board of Directors recommended a final dividend of ₹2 per equity share, representing 20% of the face value, subject to shareholder approval at the ensuing Annual General Meeting.

The audited financial results were approved by the Board at its meeting held on May 29, 2026, under Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. M/s. A.V. Subramanian & Co., Chartered Accountants, issued an audit report with an unmodified opinion on the standalone financial results for the half year and financial year ended March 31, 2026.

Financial Performance

Total income for FY26 increased to ₹9,255.89 lakh from ₹7,790.05 lakh in the previous year. Profit before tax for the year stood at ₹1,603.48 lakh, a significant increase from ₹1,034.73 lakh in FY25. Earnings per share (EPS) for the year improved to ₹6.32 from ₹4.32 in the prior year.

Capital Allocation and Dividend

The Board recommended a final dividend of ₹2 per equity share of face value ₹10 each for FY26. The company confirmed there was no deviation or variation in the utilization of proceeds raised through its Initial Public Offer (IPO) for the half year ended March 31, 2026. The total amount raised through the IPO was ₹4,200 lakh, with ₹753.29 lakh utilized as of March 31, 2026.

Corporate Governance

The Board re-appointed M/s. Pandiarajan.T & Co., Chartered Accountants, as the Internal Auditors for the financial year 2026-27. The company also confirmed it does not fall under the criteria of a 'Large Corporate' as specified in the SEBI Circular dated October 19, 2023, for the financial year ended March 31, 2026.

Hannah Joseph Hospital Limited has revised its intimation regarding the upcoming Board of Directors meeting scheduled to be held on Friday, May 29, 2026. The meeting will take place at the company's Corporate Office located at R.S. No. 115/3B2, 116/1A2, Madurai–Tuticorin Ring Road, Chinthamani, Madurai – 625009. The notification has been filed pursuant to Regulation 29(1)(a) and Regulation 29(1)(e) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to consider and approve the audited financial results of the company for the half year and financial year ended March 31, 2026. Additionally, the board will consider the recommendation of a final dividend, if any, on equity shares for the financial year ended March 31, 2026. The key details of the scheduled meeting are outlined below:

Trading Window Closure

In accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, Hannah Joseph Hospital Limited has enforced a trading window closure. The restriction applies to Directors, Designated Persons, and their immediate relatives.

• Trading window closed with effect from: April 1, 2026
• Trading window to remain closed until: 48 (Forty-Eight) hours after the declaration of the audited financial results

The revised intimation was signed by Dr. Mosesjoseph Arunkumar, Managing Director (DIN: 03608603), on May 21, 2026. The company operates as an Institute of Neurosciences, Cardiac Sciences, Orthopaedics & Traumatology and holds NABH accreditation.